Trials / Completed
CompletedNCT02529449
Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus
A Phase 2, Clinical Pharmacological Study of ASP1941 in Japanese Patients With Type 1 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess pharmacodynamics, pharmacokinetics, and safety of ASP1941 in patients with type 1 diabetes mellitus when administered once daily (q.d.) for 2 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Oral |
| DRUG | ASP1941 | Oral |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-03-19
- Completion
- 2016-03-19
- First posted
- 2015-08-20
- Last updated
- 2024-11-12
Locations
11 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02529449. Inclusion in this directory is not an endorsement.